Table 1.
Characteristics | Patients |
Age, mean (SD), y | 59.4 (13.7) |
Sex | |
Female | 27 (38) |
Male | 45 (63) |
Race | |
White | 51(71) |
Black | 12 (17) |
Hispanic | 6 (8) |
Asian | 3 (4) |
Malignancy type | |
Non-small cell lung cancer | 32 (44) |
Renal cell | 10 (14) |
Sarcoma | 6 (8) |
Colon | 4 (6) |
Thyroid | 4 (6) |
Melanoma | 3 (4) |
Breast | 2 (3) |
Head and neck | 1 (1) |
Small cell | 1 (1) |
Lymphoma | 1 (1) |
Other solid tumor metastatic to the lung | 8 (11) |
Smoking status | |
Active smoker | 5 (7) |
Ex-smoker | 44 (61) |
Never smoker | 23 (32) |
COPD | |
Yes | 11 (15) |
No | 61 (85) |
Intraoperative findings at baseline | |
Combined extrinsic and endoluminal tumor | 36 (50) |
Endoluminal tumor | 28 (39) |
Extrinsic compression only | 3 (4) |
Other | 5 (7) |
Indication was for hemoptysisa | |
Yes | 26 (36) |
No | 46 (64) |
Indication was obstruction ≥ 50% preprocedurea | |
Yes | 44 (61) |
No | 28 (39) |
Indication was obstruction < 50% preprocedurea | |
Yes | 13 (18) |
No | 59 (82) |
Stent was placed in this patient | |
Yes | 24 (33.3) |
No | 48 (66.6) |
Type of stent placedb (n = 29) | |
Ultraflex (Boston Scientific) | 15 (52) |
Aero (Merit Medical Systems, Inc) | 9 (31) |
Dumon tube stent (Novatech) | 1 (3) |
Silicone Y-stent (Novatech) | 3 (10) |
Polyflex | 1 (3) |
Degree of postprocedure airway obstruction | |
0%-49% | 66 (92) |
50%-100% | 6 (8) |
Patients had more than one interventional procedure | |
Yes | 21 (30) |
No | 51 (70) |
Preprocedure chemotherapy | |
Yes | 50 (69) |
No | 22 (31) |
Preprocedure radiation therapy | |
Yes | 38 (53) |
No | 34 (47) |
Postprocedure chemotherapy | |
Yes | 43 (60) |
No | 29 (40) |
Postprocedure radiation therapy | |
Yes | 29 (40) |
No | 43 (60) |
Data are presented as No. (%) unless indicated otherwise.
Patients could have more than one indication for intervention.
Patients could have more than one interventional procedure and/or more than one stent placed during a single procedure.